A Multi-Center, Open-label, Randomized Trial to Evaluate the Efficacy and Safety Based on Timing of Administration of DWP14012 in Patients With Erosive Esophagitis
Latest Information Update: 05 Oct 2022
At a glance
- Drugs Fexuprazan (Primary)
- Indications Erosive oesophagitis
- Focus Therapeutic Use
- 05 Oct 2022 According to ClinicalTrials.gov: US National Institutes of Health status of the trial is unknown as the information has not been verified recently(Last verified:Oct 2020).
- 05 Nov 2020 New trial record